Expression of cysteine protease inhibitors in human gliomas and meningiomas.
Increased levels of human cysteine proteases have been implicated in the progression of tumors from the premalignant to the malignant state. The physiological activities of these proteases are regulated by their interactions with specific inhibitors. To our knowledge there have been no previous reports about the cysteine protease inhibitors (CPIs) in human brain tumors. In the study reported here, we determined CPI activity during glioma progression and compared that with normal human brain tissue. We also determined CPI activities in meningioma and glioblastoma cell lines in vitro. This activity was significantly higher in normal brain tissue and low-grade glioma than in anaplastic astrocytoma and glioblastoma. CPI activity was significantly higher in benign and atypical meningioma cell extracts in comparison with those from malignant meningiomas and with those from glioblastoma cell lines. After several passages, one benign meningioma cell line showed reduced levels of CPI and increased levels of cathepsin. Our results suggest that decreases in the activities of CPI may contribute to the malignant properties of brain tumors.
Sivaparvathi
M
M
Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston 77030, USA.
McCutcheon
I
I
Sawaya
R
R
Nicolson
G L
GL
Rao
J S
JS
D001932:Brain Neoplasms / Q000378:metabolism / Q000473:pathology; D015853:Cysteine Proteinase Inhibitors / Q000096:biosynthesis*; D018450:Disease Progression; D005909:Glioblastoma / Q000473:pathology; D005910:Glioma / Q000378:metabolism*; D006801:Humans; D008579:Meningioma / Q000378:metabolism* / Q000473:pathology / Q000503:physiopathology; D014407:Tumor Cells, Cultured
D015853:Cysteine Proteinase Inhibitors